Call +44 (0)1904 798634 or +44 (0)7550 079918

Leading provider of life science market reports and research services

Items 41 to 46 of 46 total

Set Ascending Direction
per page
Page:
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Furiex Pharmaceuticals, Inc. (FURX) has announced top-line results indicating the company’s two pivotal Phase III clinical trials evaluating the efficacy and safety of eluxadoline in the treatment of ...

Read More
Comments | Posted By Claire Nicholson

Ten companies will pool data in an effort to identify promising drug targets for Alzheimer's disease, lupus and diabetes treatments.

 

Pharmaceutical companies spend billions of dollars each year develo...

Read More
Comments | Posted By Claire Nicholson

The orphan drug maker has found a home for some of its operations in the low-tax country The tax advantages of doing business in Ireland have been plumbed by a number of drugmakers, some of whom have ...

Read More

Tags:

Comments | Posted By Claire Nicholson

Global public health campaigns offer great potential to raise awareness and understanding about health issues and mobilize support for action, from the local community to the international stage. Ther...

Read More

Tags:

Comments | Posted By Claire Nicholson

Top 20 orphan drugs by 2018

03/02/2014 23:42

For a long time, pharma companies have looked to large disease populations as the biggest potential revenue streams. But those days are long gone. That perception has shifted, especially with the pres...Read More
Comments | Posted By Claire Nicholson

Items 41 to 46 of 46 total

Set Ascending Direction
per page
Page:
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5